|   |   | 
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/575 | (2006.01) | 
| A61P 25/28 | (2006.01) | ||
| C07J 9/00 | (2006.01) | 
| (11) | Number of the document | 2968369 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 14774060.9 | 
| Date of filing the European patent application | 2014-03-13 | |
| (97) | Date of publication of the European application | 2016-01-20 | 
| (45) | Date of publication and mention of the grant of the patent | 2018-08-29 | 
| (46) | Date of publication of the claims translation | 2018-12-27 | 
| (86) | Number | PCT/US2014/026784 | 
| Date | 2014-03-13 | 
| (87) | Number | WO 2014/160480 | 
| Date | 2014-10-02 | 
| (30) | Number | Date | Country code | 
| 201361779735 P | 2013-03-13 | US | 
| (72) | 
                    
                    
                    
                    
                    MARTINEZ BOTELLA, Gabriel, US  
                    
                    
                    
                    
                    HARRISON, Boyd, L., US  
                    
                    
                    
                    
                    ROBICHAUD, Albert, J., US  
                    
                    
                    
                    
                    SALITURO, Francesco, G., US  | 
| (73) | Sage Therapeutics, Inc.,
                215 First Street, Cambridge, MA 02142,
                US | 
| (74) | Reda ŽABOLIENĖ,
                METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
                LT | 
| (54) | Neuroaktyvūs steroidai ir jų panaudojimo būdai | 
| NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF | 
| Payment date | Validity (years) | Amount | |
| 2025-02-24 | 12 | 289.00 EUR | 
| 2026-03-13 |